Use access key #2 to skip to page content.
$41.47 -0.06 (-0.14%)
11/21/2008 10:02 AM

Gilead Sciences, Inc. (GILD)

CAPS Rating:
****

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

View All Commentary (GILD)

Recs

0

Avatar JThoben (53.52) Submitted: 4/03/08 8:30 AM : Outperform Start Price: $52.15 GILD Score: 23.94

Great biotech company and higher profit margin compared to it's competitor DNA. It pulls in 1.2 billion on income on about 4.5 billion of sales. DNA pulls in about 11 billion on sales and brings in only 2-3 billion.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links